We are live on ! Find out more
PCM

Parsons Capital Management Portfolio holdings

AUM $2.21B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+28.12%
3 Year Est. Return
+84.89%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.13%
AUM
$996M
AUM Growth
+$73M
Cap. Flow
-$4.39M
Cap. Flow %
-0.44%
Top 10 Hldgs %
32.34%
Holding
361
New
17
Increased
88
Reduced
159
Closed
12

Top Buys

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$11.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.4M
3
TFC icon
Truist Financial
TFC
+$2.17M
4
FENY icon
Fidelity MSCI Energy Index ETF
FENY
+$1.55M
5
IBM icon
IBM
IBM
+$1.33M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$6.06M
2
MMM icon
3M
MMM
+$6.04M
3
STI
SunTrust Banks, Inc.
STI
+$2.12M
4
STZ icon
Constellation Brands
STZ
+$1.69M
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 19.34%
2 Healthcare 13.59%
3 Financials 12.59%
4 Industrials 12.28%
5 Consumer Discretionary 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSG icon
276
iShares S&P GSCI Commodity-Indexed Trust
GSG
$968M
$357K 0.04%
22,000
– –
IFLN
277
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
$357K 0.04%
18,537
+454
+3% +$8.65K
SRLN icon
278
State Street Blackstone Senior Loan ETF
SRLN
$5.34B
$351K 0.04%
7,526
+139
+2% +$6.41K
EW icon
279
Edwards Lifesciences
EW
$51.7B
$350K 0.04%
4,503
+597
+15% +$46.6K
IMVP
280
Invesco India ETF
IMVP
$116M
$347K 0.03%
17,500
– –
DVY icon
281
iShares Select Dividend ETF
DVY
$23.6B
$335K 0.03%
3,167
-100
-3% -$10.3K
ETN icon
282
Eaton
ETN
$174B
$335K 0.03%
3,541
+26
+0.7% +$2.31K
BBY icon
283
Best Buy
BBY
$17.3B
$334K 0.03%
3,800
– –
EPS icon
284
WisdomTree US LargeCap Fund
EPS
$1.65B
$332K 0.03%
9,040
+245
+3% +$8.58K
XLE icon
285
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
$332K 0.03%
11,066
-49,046
-82% -$1.45M
FDX icon
286
FedEx
FDX
$75.4B
$328K 0.03%
2,169
-349
-14% -$53.8K
GRDX
287
GridAI Technologies Corp
GRDX
$19.2M
$328K 0.03%
3
– –
ED icon
288
Consolidated Edison
ED
$39.9B
$327K 0.03%
3,610
– –
EXPD icon
289
Expeditors International
EXPD
$23.2B
$326K 0.03%
4,175
– –
SCHX icon
290
Schwab US Large- Cap ETF
SCHX
$74.5B
$325K 0.03%
25,380
-2,550
-9% -$31.3K
BMY.RT
291
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$325K 0.03%
+107,835
New +$280K
ISRG icon
292
Intuitive Surgical
ISRG
$134B
$323K 0.03%
1,638
– –
SLF icon
293
Sun Life Financial
SLF
$45.4B
$308K 0.03%
6,767
– –
EWJ icon
294
iShares MSCI Japan ETF
EWJ
$23B
$304K 0.03%
5,125
– –
NOC icon
295
Northrop Grumman
NOC
$81.2B
$293K 0.03%
852
– –
RVTY icon
296
Revvity
RVTY
$12.8B
$291K 0.03%
3,000
– –
DSI icon
297
iShares MSCI KLD 400 Social ETF
DSI
$5.55B
$289K 0.03%
4,804
+40
+0.8% +$2.3K
DCI icon
298
Donaldson
DCI
$11.4B
$285K 0.03%
4,950
– –
TECH icon
299
Bio-Techne
TECH
$11.3B
$282K 0.03%
5,144
– –
OKE icon
300
Oneok
OKE
$54.5B
$280K 0.03%
3,700
-52
-1% -$3.72K
10 11
12
13 14

Similar funds

WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.22B AUM 20.66% 1-Year Est. Return
DPCM
Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15.01% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
NP
NS Partners London, United Kingdom $2.23B AUM 20.03% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

Parsons Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Parsons Capital Management held 361 positions worth $996M, up 7.9% from $923M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parsons Capital Management's Q4 2019 filing shows 17 new, 88 increased, 159 reduced and 12 closed positions. Its largest new stake was Relmada Therapeutics: 366,933 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $6.06M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Parsons Capital Management's largest Q4 2019 buy was Relmada Therapeutics: 366,933 shares worth $14.3M.
  • Parsons Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.4M increase.
  • Parsons Capital Management's biggest Q4 2019 reduction was 3M, cutting an estimated $6.04M.
  • Parsons Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $6.06M.
  • Parsons Capital Management's ten largest holdings make up 32% of its $996M portfolio in Q4 2019.
  • Parsons Capital Management opened 17 new positions and closed 12 in Q4 2019.
  • Parsons Capital Management's portfolio value rose 7.9% quarter-over-quarter to $996M.

Based on Parsons Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.